Research and Markets: Auto Inflammatory Disease - Pipeline Review, H2 2012 Reviews Key Players Involved In the Therapeutic Development for Auto Inflammatory Disease
Research and Markets (http://www.researchandmarkets.com/research/p3vjbm/auto_inflammatory) has announced the addition of Global Markets Direct's new report "Auto Inflammatory Disease - Pipeline Review, H2 2012" to their offering.
Global Markets Direct's, 'Auto Inflammatory Disease - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Auto Inflammatory Disease, complete with latest updates, and special features on late-stage and discontinued projects. Auto Inflammatory Disease - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
- A snapshot of the global therapeutic scenario for Auto Inflammatory Disease.
- A review of the Auto Inflammatory Disease products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Auto Inflammatory Disease pipeline on the basis of route of administration and molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.
Emergent BioSolutions Inc.
Alba Therapeutics Corporation
For more information visit http://www.researchandmarkets.com/research/p3vjbm/auto_inflammatory
Source: Global Markets Direct